Statistics

Total Visits

Views
Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.26

Select a period of time:

Number of views in the range

Views
Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.15

Views

Views
October 20240
November 20240
December 20240
January 20250
February 20250
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
 

Top cities views

Views